Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.
To evaluate the phenotypic heterogeneity of circulating tumor cells (CTCs) based on the expression of proliferative, apoptotic and Epithelial-to-Mesenchymal Transmission (EMT) markers during front-line treatment in patients with small cell lung cancer (SCLC) and to evaluate their clinical relevance....
Main Authors: | Ippokratis Messaritakis, Eleni Politaki, Athanasios Kotsakis, Eleftheria-Kleio Dermitzaki, Filippos Koinis, Eleni Lagoudaki, Anastasios Koutsopoulos, Galatea Kallergi, John Souglakos, Vassilis Georgoulias |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5515424?pdf=render |
Similar Items
-
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
by: Galatea Kallergi, et al.
Published: (2018-01-01) -
CD8 PD-1 T-cells and PD-L1 circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?
by: Athanasios Kotsakis, et al.
Published: (2019-06-01) -
Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)
by: Galatea Kallergi, et al.
Published: (2016-11-01) -
Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
by: Maria A. Papadaki, et al.
Published: (2021-01-01) -
PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
by: Eleni Tzanikou, et al.
Published: (2019-12-01)